Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection

被引:91
作者
Kassis, Ibrahim
Vaknin-Dembinsky, Adi
Karussis, Dimitrios
机构
[1] Hadassah Hebrew Univ Hosp, Dept Neurol, Jerusalem, Israel
[2] Hadassah Hebrew Univ Hosp, Lab Neuroimmunol, Jerusalem, Israel
[3] Hadassah Hebrew Univ Hosp, Agnes Ginges Ctr Neurogenet, Jerusalem, Israel
关键词
Bone marrow; mesenchymal stem cells; immunomodulation; neuroprotection; neurodegenerative diseases; multiple sclerosis (MS); amyotrophic lateral sclerosis (ALS); neurotrophic factors; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STROMAL CELLS; INTRACEREBRAL TRANSPLANTATION; LYMPHOCYTE-PROLIFERATION; PRECURSOR CELLS; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; PROGENITOR CELLS; T-LYMPHOCYTE; NK CELLS;
D O I
10.2174/157488811794480762
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mesenchymal stromal cells (MSC) are part of the bone marrow stem cells repertoire which also includes the main stem cells population of the bone marrow, the hematopoietic stem cells. The main role of MSCs is to support hematopoiesis but they can also give rise to cells of the mesodermal layers. Recently, significant interactions between MSCs and cells from the immune system have been demonstrated: MSCs were found to downregulate T and B lymphocytes, natural killer cells (NK) and antigen presenting cells through various mechanisms, including cell-to cell interaction and soluble factor production. Besides the immunomodulatory effects, MSCs were shown to possess additional stem cells features, such as the self-renewal potential and multipotency. Their debatable transdifferentiation potential to cells of the endo-and exo-dermal layer, including cells of the CNS, may explain in part their reported neuroprotective effects. Studies in vitro and in vivo (in cells cultures and in animal models) have indicated neuroprotective effects. MSCs are believed to promote functional recovery following CNS injury or inflammation, by producing trophic factors that may facilitate the mobilization of endogenous neural stem cells and promote the regeneration or the survival of the affected neurons. These immunomodulatory and neuroprotective features could make MSCs potential candidates for future therapeutic modalities in immune-mediated and neurodegenerative diseases.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 81 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]   Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma [J].
Akasaki, Y ;
Liu, G ;
Chung, NHC ;
Ehtesham, M ;
Black, KL ;
Yu, JS .
JOURNAL OF IMMUNOLOGY, 2004, 173 (07) :4352-4359
[3]   The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease [J].
Armstrong, RJE ;
Hurelbrink, CB ;
Tyers, P ;
Ratcliffe, EL ;
Richards, A ;
Dunnett, SB ;
Rosser, AE ;
Barker, RA .
EXPERIMENTAL NEUROLOGY, 2002, 175 (01) :98-111
[4]   Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway [J].
Augello, A ;
Tasso, R ;
Negrini, SM ;
Amateis, A ;
Indiveri, F ;
Cancedda, R ;
Pennesi, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (05) :1482-1490
[5]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[6]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[7]   Regulatory T cells [J].
Blazar, BR ;
Taylor, PIA .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) :46-49
[8]  
BONAB MM, 2007, IRAN J IMMUNOL, V4, P50
[9]   Neuro-glial differentiation of human bone marrow stem cells in vitro [J].
Bossolasco, P ;
Cova, L ;
Calzarossa, C ;
Rimoldi, SG ;
Borsotti, C ;
Deliliers, GL ;
Silani, V ;
Soligo, D ;
Polli, E .
EXPERIMENTAL NEUROLOGY, 2005, 193 (02) :312-325
[10]   Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats [J].
Chen, JL ;
Li, Y ;
Wang, L ;
Lu, M ;
Zhang, XH ;
Chopp, M .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 189 (1-2) :49-57